Presentations of the years 2005-2006

  • Chronic antigenic stress contributing to the immune risk profile: in vitro monitoring and in vivo impact. Lecture at the European Conference on Ageing, ECONAG, Innsbruck, 29th November, 2006 (invited by Dr. P. Jansen-Dürr).
  • Immunology and ageing. Lecture at the 6th Annual Congress of the Greek Society for Clinical Chemistry, Athens, 11th November, 2006 (invited by Dr. S. Gonos).
  • Immunotherapy, suppression and tumour progression. ASI-Lecture, Centenary Institute, University of Sydney, 27th Oct., 2006 (invited by Dr. B. Saunders).
  • Immunotherapy, suppression and tumour progression. ASI-Lecture, Queensland Institute for Medical Research, Brisbane, 25th Oct., 2006 (invited by Dr. C. Schmidt).
  • Immunosenescence. Seminar, Flinders Medical Center, Adelaide, 24th Oct., 2006 (invited by Dr. S. Heinzel).
  • Immunotherapy, suppression and tumour progression. ASI-Lecture, University of Adelaide, 23rd October, 2006 (invited by Dr. L. Dent).
  • Immunosenescence. Seminar, Monash Immunology and Stem Cell Lab, Monash Univ., Melbourne, 18th October, 2006 (invited by Pof. R. Boyd).
  • Human Immunosenescence: Is it Infectious? Lecture at the 3rd IRCHAL Conference, Melbourne, 14th October, 2006 (invited by Prof. S. Rattan).
  • Human Immunosenescence: Is it Infectious? Lecture at the Third Extramural R&D Symposium of GlaxoSmithKline Biologicals, Rixensart, 9th October, 2006 (invited by Dr. M. Chevalier).
  • Is it still worthwhile seeking individual tumour antigens for use in cancer immunotherapy? Lecture at PIVAC 6, Granada, 28th September, 2006 (invited by Prof. F. Garrido).
  • Biomarkers of Immune Ageing: the Immune Risk Profile. Lecture at the 5th Eur. Congress of Biogerontology, Istanbul, 18th September, 2006 (invted by Prof. S. Akman).
  • Impact of CMV on Immunosenescence and Human Longevity. Lecture at the ARIG Conference, Paris, 4th September, 2006 (invited by Prof. B. Grubeck-Loebenstein).
  • The immune risk profile in the very elderly. Lecture, Human Immunology Grand Rounds, Emory University, Atlanta, 21st July (invited by Prof. C. Weyand).
  • Longitudinal studies implicate CMV in accelerating human immunosenescence. “Immunology Forum Seminar”, UCLA, 20th July, 2006 (invited by Prof. R. Effros).
  • Immunosenescence. Lecture at the FNRS Contact Group on Human Vaccines, Liège, 16th June, 2006 (invited by Prof. M. Goldman).
  • Immunotherapy, immunosenescence, suppression and tumour progression. Seminar at the Dept. Biochemistry, Jagellionian University, Krakow, 19th May, 2006 (invited by Prof. P. Laidler).
  • The Immune Risk Profile in the very Elderly. Lecture at the Session on Immunosenescence of the AAI Annual Meeting. Boston, 13th May, 2006 (invited by Prof. S. Swain).
  • Age and Immunity. Lecture to the IFIB, Tübingen, 24th April, 2006 (invited by Prof. W. Voelter).
  • Is it still worthwhile seeking individual tumour antigens for use in cancer immunotherapy? Lecture at the NCI, NIH, Federick, 7th April 2006 (invited by Dr. T. Sayers).
  • Longitudinal studies of free-living elderly reveal an immune risk profile associated with decreased remaining survival. Lecture at the NIA, NIH, Bethesda, 6th April 2006 (invited by Dr. E. Hadley).
  • Immunotherapy, immunosenescence, suppression and tumour progression. Lecture at Nottingham Trent University, 6th March, 2006 (invited by Dr. M. Ahmad).
  • Human T cell clones as models for Immunosenescence: Effect of supplementary zinc. Lecture at the 2nd ZINCAGE Symposium, Madrid, 12th February, 2006 (invited by Dr. E. Mocchegiani).
  • Immunosensecence, suppression and tumour progression. Lecture at the BSI Annual Congress, Harrogate, 8th December, 2005 (invited by Dr. D.L. Morgan).
  • Is immunosenescence infectious? Lecture at the Annual meeting of the German Society for Gerontology and Geriatrics, Lübeck, 13th October, 2005 (invited by PD Dr. C. Meissner).
  • CMV and the Immune Risk Profile. Lecture at the International Workshop on Differentiation and Immunosenescence in the Immune System, Compton, 7th October, 2005 (invited by Prof. P. Beverley).
  • Immunosenescence: a disease of chronic antigenic stimulation? Lecture at the “Successful Aging” Symposium, Warsaw, 3rd October, 2005 (invited by Prof. E. Sikora).
  • Age & Immunity. Seminar at the National Hellenic Research Foundation, Athens, 22nd September 2005 (invited by Prof. E. Gonos).
  • Immunorejuvenation in the elderly. Lecture at the 2nd Strategies for Engineering Negligible Senescence conference, Cambridge, 9th Seprtember, 2005 (invited by Dr. A. de Grey).
  • Is immunosenescence infectious? Lecture at the 11th Congress of the Int Assoc for Biomedical Gerontology, Aarhus, 15th August 2005 (invited by Prof. S. Rattan).
  • Immunosensecence, suppression and tumour progression. Lecture at the Bob Baldwin 50th Anniversary Symposium, Nottingham, 30th June, 2005 (invited by Prof. L. Durrant).
  • Is Immunosenescence Contagious? Seminar at the GBF, Braunschweig, 4th May, 2005 (invited by Dr. E. Wollscheid-Lengeling).
  • Is Immunosenescence Contagious? Lecture at the Immunology and Alzheimer´s conference, Montreal, 17th March, 2005 (invited by Prof. T. Fülöp)